Clinical Trial Update: Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating omega-3 fatty acid supplementation added to ADHD pharmacotherapy in adults with ADHD and DESR; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Deficient Emotional Self-regulation

Drugs mentioned

• Omega-3 fatty acid supplementation (Omega-3 fatty acids)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Deficient Emotional Self-Regulation (DESR) | Phase 2 | Status: COMPLETED | Results posted: 2018-10-23